{
  "animalStudies": {
    "name": "Animal Studies",
    "categories": {
      "pharmacodynamics": {
        "name": "Pharmacodynamics",
        "subcategories": {
          "primary": {
            "name": "Primary Pharmacodynamics",
            "types": {
              "invivo": {
                "name": "In Vivo",
                "keywords": [
                  "In vivo Pharmacodynamics",
                  "Animal Models",
                  "Dose-Response Relationship, Drug",
                  "Drug Effects",
                  "Receptor Binding",
                  "Therapeutic Effect",
                  "Pharmacologic Action",
                  "Signal Transduction",
                  "Dynamic Drug Concentrations"
                ],
                "meshTerms": [
                  "In vivo Pharmacodynamics[MeSH]",
                  "Animal Models[MeSH]",
                  "Dose-Response Relationship, Drug[MeSH]",
                  "Drug Effects[MeSH]",
                  "Receptor Binding[MeSH]"
                ],
                "textKeywords": [
                  "Therapeutic Effect[tiab]",
                  "Pharmacologic Action[tiab]",
                  "Signal Transduction[tiab]",
                  "Dynamic Drug Concentrations[tiab]"
                ]
              },
              "invitro": {
                "name": "In Vitro",
                "keywords": [
                  "In vitro Pharmacodynamics",
                  "Cell Line, Tumor",
                  "Receptor Ligand Binding",
                  "Enzyme Inhibition",
                  "Binding Assay",
                  "Cell Culture Technique",
                  "In vitro Antimicrobial Activity"
                ],
                "meshTerms": [
                  "In vitro Pharmacodynamics[MeSH]",
                  "Cell Line, Tumor[MeSH]",
                  "Receptor Ligand Binding[MeSH]",
                  "Enzyme Inhibition[MeSH]",
                  "Cell Culture Technique[MeSH]",
                  "In vitro Antimicrobial Activity[MeSH]"
                ],
                "textKeywords": [
                  "Binding Assay[tiab]"
                ]
              }
            }
          },
          "secondary": {
            "name": "Secondary Pharmacodynamics",
            "types": {
              "general": {
                "name": "Secondary Pharmacological Actions",
                "keywords": [
                  "Secondary Pharmacological Actions",
                  "Off-Target Effects",
                  "Adverse Drug Reaction",
                  "Non-Specific Drug Effects",
                  "Side Effects",
                  "Downstream Signaling",
                  "Pharmacological Profiling",
                  "Secondary PD studies",
                  "Pharmacodynamic safety studies animal models",
                  "In vivo pharmacology animal studies",
                  "Safety pharmacology",
                  "Dose-response effects nonclinical",
                  "Receptor binding off-target",
                  "Secondary pharmacology endpoints",
                  "safety pharmacology studies",
                  "Dose-Response Relationship",
                  "Off-target pharmacological effects",
                  "Animal safety pharmacology data",
                  "Pharmacodynamics",
                  "Pharmacodynamic effects",
                  "Toxicodynamics",
                  "Therapeutic other effects",
                  "Therapeutic effects",
                  "Animals"
                ],
                "meshTerms": [
                  "Adverse Drug Reaction[MeSH]",
                  "Animals[MeSH]",
                  "Dose-Response Relationship, Drug[MeSH]",
                  "Pharmacodynamics[MeSH]",
                  "Toxicodynamics[MeSH]"
                ],
                "textKeywords": [
                  "Secondary Pharmacological Actions[tiab]",
                  "Off-Target Effects[tiab]",
                  "Non-Specific Drug Effects[tiab]",
                  "Side Effects[tiab]",
                  "Downstream Signaling[tiab]",
                  "Pharmacological Profiling[tiab]",
                  "Secondary PD studies[tiab]",
                  "Pharmacodynamic safety studies[tiab]",
                  "In vivo pharmacology[tiab]",
                  "Safety pharmacology[tiab]",
                  "Dose-response effects nonclinical[tiab]",
                  "Receptor binding off-target[tiab]",
                  "Secondary pharmacology endpoints[tiab]",
                  "Off-target pharmacological effects[tiab]",
                  "Animal safety pharmacology data[tiab]",
                  "Pharmacodynamic effects[tiab]",
                  "Therapeutic effects[tiab]"
                ]
              },
              "interaction": {
                "name": "Pharmacodynamic Drug Interaction",
                "keywords": [
                  "Pharmacodynamic Interaction",
                  "Drug Synergism",
                  "Drug Antagonism",
                  "Drug Interaction",
                  "Receptor Competition",
                  "Effect Modification",
                  "Therapeutic Drug Monitoring"
                ],
                "meshTerms": [
                  "Pharmacodynamic Interaction[MeSH]",
                  "Drug Synergism[MeSH]",
                  "Drug Antagonism[MeSH]",
                  "Drug Interaction[MeSH]",
                  "Therapeutic Drug Monitoring[MeSH]"
                ],
                "textKeywords": [
                  "Receptor Competition[tiab]",
                  "Effect Modification[tiab]"
                ]
              }
            }
          }
        }
      },
      "safetyPharmacology": {
        "name": "Safety Pharmacology",
        "keywords": [
          "Safety",
          "Adverse effects",
          "Adverse reactions",
          "Adverse",
          "Adverse effect",
          "Toxic effects",
          "Safety Pharmacology",
          "Animals",
          "Drug-Related Side Effects and Adverse Reactions",
          "Toxicodynamics",
          "Cardiovascular Diseases / chemically induced",
          "Central Nervous System Diseases / chemically induced",
          "Respiratory Tract Diseases / chemically induced",
          "Risk Assessment",
          "Cardiovascular, CNS, respiratory safety pharmacology"
        ],
        "meshTerms": [
          "Safety[MeSH]",
          "Drug-Related Side Effects and Adverse Reactions[MeSH]",
          "Animals[MeSH]",
          "Toxicodynamics[MeSH]",
          "Cardiovascular Diseases[MeSH]",
          "Central Nervous System Diseases[MeSH]",
          "Respiratory Tract Diseases[MeSH]",
          "Risk Assessment[MeSH]"
        ],
        "textKeywords": [
          "Safety[tiab]",
          "Adverse effects[tiab]",
          "Adverse reactions[tiab]",
          "Toxic effects[tiab]",
          "Safety Pharmacology[tiab]",
          "Toxicodynamics[tiab]",
          "Cardiovascular safety pharmacology[tiab]",
          "CNS safety pharmacology[tiab]",
          "respiratory safety pharmacology[tiab]"
        ],
        "subcategories": {
          "cns": {
            "name": "Effect on Central Nervous System (CNS)",
            "keywords": [
              "Central Nervous System",
              "Neurotoxicity",
              "Behavioral Toxicity",
              "Neuropharmacology",
              "Seizures",
              "Locomotor Activity",
              "Cognitive Dysfunction",
              "Neurotransmitter Release",
              "Motor Coordination",
              "Safety",
              "Adverse effects",
              "Adverse reactions",
              "Adverse",
              "Adverse effect",
              "Animals",
              "Cns",
              "Brain",
              "Motor Activity",
              "Neurotoxicity Syndromes",
              "Drug abuse and dependence liability"
            ],
            "meshTerms": [
              "Central Nervous System[MeSH]",
              "Neurotoxicity[MeSH]",
              "Behavioral Toxicity[MeSH]",
              "Neuropharmacology[MeSH]",
              "Seizures[MeSH]",
              "Locomotor Activity[MeSH]",
              "Cognitive Dysfunction[MeSH]",
              "Animals[MeSH]",
              "Brain[MeSH]",
              "Motor Activity[MeSH]",
              "Neurotoxicity Syndromes[MeSH]"
            ],
            "textKeywords": [
              "Neurotransmitter Release[tiab]",
              "Motor Coordination[tiab]",
              "Safety[tiab]",
              "Adverse effects[tiab]",
              "CNS[tiab]",
              "Neurotoxicity Syndromes[tiab]",
              "Drug abuse and dependence liability[tiab]"
            ]
          },
          "cvs": {
            "name": "Effect on Cardiovascular System (CVS)",
            "keywords": [
              "Cardiovascular System",
              "Cardiotoxicity",
              "Electrocardiography",
              "QT Interval",
              "hERG Channel",
              "Arrhythmia",
              "Hemodynamics",
              "Blood Pressure",
              "Heart Rate",
              "Adverse effects",
              "Adverse reactions",
              "Adverse",
              "Adverse effect",
              "Safety",
              "Safety pharmacology",
              "Animals",
              "Cardiovascular Diseases",
              "Cvs",
              "Heart",
              "EKG",
              "QT interval prolongation",
              "ERG channel assay",
              "Purkinje fiber assay"
            ],
            "meshTerms": [
              "Cardiovascular System[MeSH]",
              "Cardiotoxicity[MeSH]",
              "Electrocardiography[MeSH]",
              "QT Interval[MeSH]",
              "Arrhythmia[MeSH]",
              "Hemodynamics[MeSH]",
              "Blood Pressure[MeSH]",
              "Heart Rate[MeSH]",
              "Animals[MeSH]",
              "Cardiovascular Diseases[MeSH]",
              "Heart[MeSH]"
            ],
            "textKeywords": [
              "hERG Channel[tiab]",
              "Safety[tiab]",
              "Adverse effects[tiab]",
              "CVS[tiab]",
              "EKG[tiab]",
              "QT interval prolongation[tiab]",
              "ERG channel assay[tiab]",
              "Purkinje fiber assay[tiab]"
            ]
          },
          "other": {
            "name": "Other Effects",
            "keywords": [
              "Respiratory System",
              "Respiratory Function Tests",
              "Renal Toxicity",
              "Hepatotoxicity",
              "Gastrointestinal Toxicity",
              "Genotoxicity",
              "Immunotoxicity",
              "Toxicity Testing",
              "Animal Welfare",
              "Respiratory Tract Diseases / chemically induced",
              "Respiratory Rate",
              "Tidal Volume",
              "Gastrointestinal Motility",
              "Salivation / drug effects",
              "Body Temperature regulation",
              "Autonomic Nervous System Effects",
              "Gastrointestinal safety pharmacology",
              "GI motility effects",
              "Nausea and vomiting drug-induced",
              "Diarrhea adverse effects",
              "Constipation drug effects",
              "Gastric secretion modulation",
              "Gastric emptying rate impact",
              "Dyspepsia drug-related",
              "Abdominal pain drug-induced",
              "Enteric nervous system effects",
              "Secretory function gastrointestinal",
              "GI tract toxicity",
              "Gastrointestinal adverse event risk",
              "GI inflammation pharmacology",
              "GI receptor modulation",
              "Gastrointestinal transit time",
              "Safety pharmacology enteric effects",
              "GI barrier function",
              "Abdominal Pain"
            ],
            "meshTerms": [
              "Respiratory System[MeSH]",
              "Respiratory Function Tests[MeSH]",
              "Renal Toxicity[MeSH]",
              "Hepatotoxicity[MeSH]",
              "Gastrointestinal Toxicity[MeSH]",
              "Genotoxicity[MeSH]",
              "Immunotoxicity[MeSH]",
              "Toxicity Testing[MeSH]",
              "Animal Welfare[MeSH]",
              "Respiratory Tract Diseases[MeSH]",
              "Gastrointestinal Motility[MeSH]",
              "Salivation[MeSH]",
              "Body Temperature Regulation[MeSH]",
              "Autonomic Nervous System[MeSH]",
              "Abdominal Pain[MeSH]"
            ],
            "textKeywords": [
              "Respiratory Rate[tiab]",
              "Tidal Volume[tiab]",
              "GI motility effects[tiab]",
              "Nausea and vomiting drug-induced[tiab]",
              "Diarrhea adverse effects[tiab]",
              "Constipation drug effects[tiab]",
              "Gastric secretion modulation[tiab]",
              "Gastric emptying rate impact[tiab]",
              "Dyspepsia drug-related[tiab]",
              "Abdominal pain drug-induced[tiab]",
              "Enteric nervous system effects[tiab]",
              "GI tract toxicity[tiab]",
              "Gastrointestinal adverse event risk[tiab]",
              "GI inflammation pharmacology[tiab]",
              "GI receptor modulation[tiab]",
              "Gastrointestinal transit time[tiab]",
              "Safety pharmacology enteric effects[tiab]",
              "GI barrier function[tiab]"
            ]
          }
        }
      },
      "pharmacokinetics": {
        "name": "Pharmacokinetics",
        "keywords": [
          "Pharmacokinetic",
          "Pharmacokinetics",
          "Pharmaco-kinetic",
          "Pharma-cokinetic",
          "PK",
          "kinetic",
          "kinetics",
          "ADME"
        ],
        "meshTerms": [
          "Pharmacokinetics[MeSH]"
        ],
        "textKeywords": [
          "Pharmacokinetic[tiab]",
          "Pharmacokinetics[tiab]",
          "Pharmaco-kinetic[tiab]",
          "Pharma-cokinetic[tiab]",
          "PK[tiab]",
          "kinetic[tiab]",
          "kinetics[tiab]",
          "ADME[tiab]"
        ],
        "subcategories": {
          "methodOfAnalysis": {
            "name": "Method of Analysis",
            "keywords": [
              "Pharmacokinetic and HPLC",
              "Pharmacokinetic and High-performance liquid chromatography",
              "Pharmacokinetic and LC-MS",
              "Pharmacokinetic and LCMS",
              "Pharmacokinetic and Liquid chromatography-mass spectrometry",
              "Pharmacokinetic and Liquid chromatography mass spectrometry",
              "Bioanalytical Techniques",
              "Quantitative Assay"
            ],
            "meshTerms": [
              "Pharmacokinetics[MeSH]",
              "Bioanalytical Techniques[MeSH]",
              "Liquid Chromatography-Mass Spectrometry[MeSH]",
              "Chromatography, High Pressure Liquid[MeSH]"
            ],
            "textKeywords": [
              "HPLC[tiab]",
              "LC-MS[tiab]",
              "LCMS[tiab]",
              "High-performance liquid chromatography[tiab]",
              "Liquid chromatography-mass spectrometry[tiab]",
              "Bioanalytical Method[tiab]",
              "Analytical Method[tiab]"
            ]
          },
          "absorption": {
            "name": "Absorption",
            "keywords": [
              "Pharmacokinetic and bioavailability",
              "Pharmacokinetic and bio-availability",
              "Pharmacokinetic and absorption",
              "Pharmacokinetic and absorbed",
              "Pharmacokinetic and Cmax",
              "Pharmacokinetic and CMAX",
              "Pharmacokinetic and C max",
              "Pharmacokinetic and tmax",
              "Pharmacokinetic and TMAX",
              "Pharmacokinetic and T max",
              "Pharmacokinetic and AUC",
              "Pharmacokinetic and maximum drug concentration",
              "Pharmacokinetic and peak concentration",
              "Pharmacokinetic and time to peak",
              "Pharmacokinetic and area under the curve",
              "Pharmacokinetic and area-under the curve",
              "Drug Absorption",
              "First-Pass Effect",
              "CMAX",
              "TMAX",
              "Cmax",
              "Tmax"
            ],
            "meshTerms": [
              "Biological Availability[MeSH]",
              "Intestinal Absorption[MeSH]",
              "Area Under Curve[MeSH]"
            ],
            "textKeywords": [
              "bioavailability[tiab]",
              "bio-availability[tiab]",
              "absorption[tiab]",
              "absorbed[tiab]",
              "Cmax[tiab]",
              "CMAX[tiab]",
              "C max[tiab]",
              "tmax[tiab]",
              "TMAX[tiab]",
              "T max[tiab]",
              "AUC[tiab]",
              "maximum drug concentration[tiab]",
              "peak concentration[tiab]",
              "peak plasma concentration[tiab]",
              "time to peak[tiab]",
              "time to maximum concentration[tiab]",
              "area under the curve[tiab]",
              "area-under the curve[tiab]"
            ]
          },
          "distribution": {
            "name": "Distribution",
            "keywords": [
              "Pharmacokinetic and Volume of distribution",
              "Pharmacokinetic and distribution",
              "Pharmacokinetic and protein binding",
              "Pharmacokinetic and cytochrome",
              "Pharmacokinetic and Vd",
              "Tissue Distribution",
              "Blood-Brain Barrier"
            ],
            "meshTerms": [
              "Tissue Distribution[MeSH]",
              "Protein Binding[MeSH]",
              "Blood-Brain Barrier[MeSH]"
            ],
            "textKeywords": [
              "Volume of distribution[tiab]",
              "distribution[tiab]",
              "protein binding[tiab]",
              "cytochrome[tiab]",
              "Vd[tiab]"
            ]
          },
          "metabolism": {
            "name": "Metabolism",
            "keywords": [
              "Pharmacokinetic and metabolism",
              "Pharmacokinetic and metabolizm",
              "Pharmacokinetic and cytochrome",
              "Pharmacokinetic and metabolite",
              "Pharmacokinetic and biotransformation",
              "Pharmacokinetic and bio-transformation",
              "Pharmacokinetic and CYP",
              "Cytochrome P450 Enzymes",
              "Phase I Metabolism",
              "Phase II Metabolism"
            ],
            "meshTerms": [
              "Metabolic Clearance Rate[MeSH]",
              "Cytochrome P-450 Enzyme System[MeSH]",
              "Biotransformation[MeSH]"
            ],
            "textKeywords": [
              "metabolism[tiab]",
              "metabolizm[tiab]",
              "cytochrome[tiab]",
              "metabolite[tiab]",
              "biotransformation[tiab]",
              "bio-transformation[tiab]",
              "CYP[tiab]"
            ]
          },
          "excretion": {
            "name": "Excretion",
            "keywords": [
              "Pharmacokinetic and Excretion",
              "Pharmacokinetic and elimination",
              "Pharmacokinetic and clearance",
              "Pharmacokinetic and half life",
              "Pharmacokinetic and half-life",
              "Pharmacokinetic and t1/2",
              "Renal Clearance",
              "Biliary Excretion"
            ],
            "meshTerms": [
              "Kidney[MeSH]",
              "Metabolic Clearance Rate[MeSH]",
              "Half-Life[MeSH]"
            ],
            "textKeywords": [
              "Excretion[tiab]",
              "elimination[tiab]",
              "clearance[tiab]",
              "half life[tiab]",
              "half-life[tiab]",
              "t1/2[tiab]"
            ]
          },
          "specialPopulations": {
            "name": "Pharmacokinetics in Special Populations",
            "keywords": [
              "Pharmacokinetic in renal impairment",
              "Pharmacokinetic and kidney impairment",
              "Pharmacokinetic and renal impairment",
              "Pharmacokinetic and end stage renal disease",
              "Pharmacokinetic and renal disease",
              "Pharmacokinetic and kidney disease",
              "Pharmacokinetic and kidney dysfunction",
              "Pharmacokinetic and renal dysfunction",
              "Pharmacokinetic in hepatic impairment",
              "Pharmacokinetic and liver impairment",
              "Pharmacokinetic and hepatic impairment",
              "Pharmacokinetic and hepatic cirrhosis",
              "Pharmacokinetic and liver cirrhosis",
              "Pharmacokinetic and liver disease",
              "Pharmacokinetic and liver dysfunction",
              "Pharmacokinetic and hepatic dysfunction",
              "Pharmacokinetic and elderly",
              "Pharmacokinetic and paediatrics",
              "Pharmacokinetic and adolescent",
              "Pharmacokinetic and adolescents",
              "Pharmacokinetic and older",
              "Pharmacokinetic and pediatrics",
              "Pharmacokinetic and pediatric",
              "Pharmacokinetic and paediatric",
              "Pharmacokinetic and pregnancy",
              "Pharmacokinetic and race"
            ],
            "meshTerms": [
              "Renal Insufficiency[MeSH]",
              "Liver Cirrhosis[MeSH]",
              "Aged[MeSH]",
              "Child[MeSH]",
              "Adolescent[MeSH]",
              "Pregnancy[MeSH]"
            ],
            "textKeywords": [
              "renal impairment[tiab]",
              "kidney impairment[tiab]",
              "end stage renal disease[tiab]",
              "renal disease[tiab]",
              "kidney disease[tiab]",
              "kidney dysfunction[tiab]",
              "renal dysfunction[tiab]",
              "hepatic impairment[tiab]",
              "liver impairment[tiab]",
              "hepatic cirrhosis[tiab]",
              "liver cirrhosis[tiab]",
              "liver disease[tiab]",
              "liver dysfunction[tiab]",
              "hepatic dysfunction[tiab]",
              "elderly[tiab]",
              "paediatrics[tiab]",
              "adolescent[tiab]",
              "adolescents[tiab]",
              "pediatrics[tiab]",
              "pediatric[tiab]",
              "paediatric[tiab]",
              "pregnancy[tiab]",
              "race[tiab]",
              "gender[tiab]",
              "age[tiab]"
            ]
          },
          "drugInteraction": {
            "name": "Pharmacokinetics Drug Interaction",
            "keywords": [
              "Pharmacokinetic drug interaction",
              "Pharmacokinetic and interaction",
              "Pharmacokinetic and drug interaction",
              "Pharmacokinetic and population pharmacokinetics",
              "Pharmacokinetic and population pharmacokinetic"
            ],
            "meshTerms": [
              "Drug Interactions[MeSH]"
            ],
            "textKeywords": [
              "drug interaction[tiab]",
              "interaction[tiab]",
              "population pharmacokinetics[tiab]",
              "population pharmacokinetic[tiab]"
            ]
          },
          "other": {
            "name": "Other Pharmacokinetics Studies",
            "keywords": [
              "Pharmacokinetic Variability",
              "Dose Proportionality",
              "Pharmacokinetic Modeling",
              "Non-Compartmental Analysis",
              "Therapeutic Drug Monitoring"
            ],
            "meshTerms": [
              "Models, Biological[MeSH]",
              "Drug Monitoring[MeSH]"
            ],
            "textKeywords": [
              "Dose Proportionality[tiab]",
              "Pharmacokinetic Modeling[tiab]",
              "Non-Compartmental Analysis[tiab]",
              "population pharmacokinetics[tiab]"
            ]
          }
        }
      },
      "toxicology": {
        "name": "Toxicology",
        "keywords": [
          "Adverse effect",
          "Toxic",
          "Toxicity",
          "Adverse reaction",
          "Acute toxicity",
          "Repeated dose toxicity",
          "Chronic toxicity",
          "Genotoxicity",
          "Carcinogenicity",
          "Reproductive toxicity",
          "Toxicokinetics",
          "NOAEL (No Observed Adverse Effect Level)",
          "Target organs",
          "Onset, severity, and duration of toxic effects",
          "Immunotoxicity",
          "Phototoxicity"
        ],
        "meshTerms": [
          "Toxicity[MeSH]",
          "Acute Toxicity[MeSH]",
          "Chronic Toxicity[MeSH]",
          "Genotoxicity[MeSH]",
          "Carcinogenicity[MeSH]",
          "Reproductive Toxicity[MeSH]",
          "Toxicokinetics[MeSH]",
          "Immunotoxicity[MeSH]",
          "Phototoxicity[MeSH]"
        ],
        "textKeywords": [
          "Adverse effect[tiab]",
          "Toxic[tiab]",
          "Toxicity[tiab]",
          "Adverse reaction[tiab]",
          "Repeated dose toxicity[tiab]",
          "NOAEL[tiab]",
          "No Observed Adverse Effect Level[tiab]",
          "Target organs[tiab]",
          "toxic effects[tiab]"
        ],
        "subcategories": {
          "singleDose": {
            "name": "Single Dose Toxicity",
            "keywords": [
              "Acute Toxicity",
              "Single Dose Toxicity",
              "Dose Escalation",
              "Toxicological Evaluation",
              "Single-Dose Toxicity",
              "Toxicity",
              "Safety",
              "Adverse events",
              "Adverse effects",
              "Adverse",
              "Safe",
              "Species (order by species)",
              "Route of administration",
              "Maximum non-lethal dose",
              "Approximate lethal dose (LD50)",
              "Dose(s) tested",
              "Vehicle/formulation",
              "Number of animals/group",
              "Gender/strain/age of animals",
              "Toxic signs",
              "Onset, severity, duration of toxic effects",
              "Dose dependency",
              "Reversibility of effects (reversible/irreversible)",
              "Pathologic findings",
              "Causes of death",
              "Study methodology brief summary",
              "GLP compliance status",
              "Special features of study (e.g., infusion rate, duration)",
              "Toxicokinetics"
            ],
            "meshTerms": [
              "Acute Toxicity[MeSH]",
              "Toxicity[MeSH]",
              "Safety[MeSH]",
              "Lethal Dose 50[MeSH]",
              "Toxicokinetics[MeSH]"
            ],
            "textKeywords": [
              "Single Dose Toxicity[tiab]",
              "Dose Escalation[tiab]",
              "Toxicological Evaluation[tiab]",
              "Single-Dose Toxicity[tiab]",
              "Maximum non-lethal dose[tiab]",
              "Approximate lethal dose[tiab]",
              "LD50[tiab]",
              "Dose dependency[tiab]",
              "Reversibility of effects[tiab]",
              "Pathologic findings[tiab]",
              "GLP compliance[tiab]"
            ]
          },
          "repeatDose": {
            "name": "Repeat Dose Toxicity",
            "keywords": [
              "Subchronic Toxicity",
              "Chronic Toxicity",
              "Repeat Dose Toxicity",
              "Toxicity Studies",
              "Dose-Response Relationship, Drug",
              "Repeat Dose Toxicity",
              "Multiple Dose toxicity",
              "Toxicity",
              "Toxic",
              "Adverse effect",
              "Adverse events",
              "Adverse",
              "Safe",
              "Repeat dose",
              "Special study features (e.g., nutritional support, vehicle control)",
              "Safety margins relative to human exposure",
              "Dose-response relationships",
              "Study design summary (animals per group, gender, strain, age)",
              "Target organs of toxicity",
              "Histopathology findings",
              "Clinical signs and symptoms observed",
              "Nature and severity of toxic effects",
              "Reversibility of toxic changes",
              "Systemic exposure (e.g., blood levels, AUC, Cmax)",
              "Toxicokinetics evaluation",
              "Species (rodent and non-rodent)",
              "Route of administration",
              "Duration of dosing (e.g., 28-day, 90-day, sub-chronic, chronic)",
              "Dose levels (low, mid, high)",
              "Maximum tolerated dose (MTD)",
              "No Observed Adverse Effect Level (NOAEL)"
            ],
            "meshTerms": [
              "Subchronic Toxicity[MeSH]",
              "Chronic Toxicity[MeSH]",
              "Dose-Response Relationship, Drug[MeSH]",
              "Toxicity[MeSH]",
              "Toxicokinetics[MeSH]",
              "Maximum Tolerated Dose[MeSH]"
            ],
            "textKeywords": [
              "Repeat Dose Toxicity[tiab]",
              "Toxicity Studies[tiab]",
              "Multiple Dose toxicity[tiab]",
              "Repeat dose[tiab]",
              "Safety margins[tiab]",
              "Target organs of toxicity[tiab]",
              "Histopathology findings[tiab]",
              "Clinical signs and symptoms[tiab]",
              "Reversibility of toxic changes[tiab]",
              "Systemic exposure[tiab]",
              "Toxicokinetics evaluation[tiab]",
              "Duration of dosing[tiab]",
              "Maximum tolerated dose[tiab]",
              "MTD[tiab]",
              "NOAEL[tiab]"
            ]
          },
          "genotoxicity": {
            "name": "Genotoxicity",
            "keywords": [
              "Genotoxicity Tests",
              "Mutagenicity Tests",
              "DNA Damage",
              "Chromosome Aberrations",
              "Ames Test",
              "Genotoxicity",
              "Genotoxic",
              "Toxic",
              "Toxicity",
              "Adverse effects",
              "Adverse",
              "Adverse events",
              "Mutagenicity",
              "In vitro tests",
              "In vivo tests",
              "Gene mutation assays (e.g., Ames test, HPRT, TK gene mutation)",
              "Chromosomal aberration assay",
              "Micronucleus assay",
              "Clastogenicity",
              "Aneuploidy",
              "DNA damage/repair assays",
              "Somatic cell assays",
              "Germ cell assays",
              "DNA adduct formation",
              "Mode of action",
              "Dose-response relationship",
              "Threshold concept for mutagenicity",
              "Regulatory guidelines (e.g., OECD, ICH S2)",
              "Interpretation of positive/negative results",
              "Risk assessment",
              "Study methodology summary",
              "Test substance characterization",
              "Compliance with GLP"
            ],
            "meshTerms": [
              "Genotoxicity Tests[MeSH]",
              "Mutagenicity Tests[MeSH]",
              "DNA Damage[MeSH]",
              "Chromosome Aberrations[MeSH]",
              "Mutagenicity[MeSH]",
              "Micronucleus Tests[MeSH]",
              "Risk Assessment[MeSH]"
            ],
            "textKeywords": [
              "Ames Test[tiab]",
              "Genotoxicity[tiab]",
              "Genotoxic[tiab]",
              "Mutagenicity[tiab]",
              "In vitro tests[tiab]",
              "In vivo tests[tiab]",
              "Gene mutation assays[tiab]",
              "Chromosomal aberration assay[tiab]",
              "Micronucleus assay[tiab]",
              "Clastogenicity[tiab]",
              "Aneuploidy[tiab]",
              "DNA damage/repair assays[tiab]",
              "DNA adduct formation[tiab]",
              "Mode of action[tiab]",
              "Threshold concept for mutagenicity[tiab]",
              "OECD guidelines[tiab]",
              "ICH S2[tiab]"
            ]
          },
          "carcinogenicity": {
            "name": "Carcinogenicity",
            "keywords": [
              "Carcinogenicity",
              "Neoplasms, Experimental",
              "Tumor Promotion",
              "Oncogenesis",
              "Carcinogenecity",
              "Carcinogene",
              "Toxicity",
              "Adverse effects",
              "Adverse events",
              "Safe",
              "Safety",
              "Carcinogenic risk assessment",
              "Tumor incidence",
              "TD50 value (tumorigenic dose 50)",
              "Dose-response relationship",
              "2-year rodent bioassay",
              "Tumor type and site",
              "Histopathology findings",
              "Onset, severity, duration of tumor development",
              "Mode of action (MOA)",
              "Genotoxicity and mutagenicity relationship",
              "Species and sex differences",
              "Exposure levels (AUC, Cmax)",
              "Epidemiologic data (if available)",
              "Weight of Evidence (WoE) approach",
              "Off-target effects",
              "Regulatory guidelines (e.g., ICH S1A, S1B)",
              "GLP compliance",
              "Secondary pharmacology related to carcinogenesis",
              "Negative vs. positive carcinogenic findings",
              "Tumor latency period",
              "Risk to humans prediction",
              "Molecular markers of carcinogenesis"
            ],
            "meshTerms": [
              "Carcinogenicity[MeSH]",
              "Neoplasms, Experimental[MeSH]",
              "Oncogenesis[MeSH]",
              "Toxicity[MeSH]",
              "Safety[MeSH]",
              "Risk Assessment[MeSH]",
              "Genotoxicity[MeSH]"
            ],
            "textKeywords": [
              "Tumor Promotion[tiab]",
              "Carcinogenecity[tiab]",
              "Carcinogene[tiab]",
              "Carcinogenic risk assessment[tiab]",
              "Tumor incidence[tiab]",
              "TD50[tiab]",
              "tumorigenic dose 50[tiab]",
              "2-year rodent bioassay[tiab]",
              "Tumor type and site[tiab]",
              "Mode of action[tiab]",
              "MOA[tiab]",
              "Species and sex differences[tiab]",
              "Weight of Evidence[tiab]",
              "WoE approach[tiab]",
              "ICH S1A[tiab]",
              "ICH S1B[tiab]",
              "Tumor latency period[tiab]",
              "Molecular markers of carcinogenesis[tiab]"
            ]
          },
          "reproductiveToxicity": {
            "name": "Reproductive and Developmental Toxicity",
            "keywords": [
              "Reproductive Toxicity",
              "Developmental Toxicity",
              "Fertility (male and female)",
              "Embryo-fetal development",
              "Prenatal development",
              "Postnatal development",
              "Teratogenicity (structural abnormalities)",
              "Functional impairments",
              "Embryotoxicity",
              "Growth retardation",
              "Neurodevelopmental effects",
              "Parturition and lactation effects",
              "Gametogenesis disruption",
              "Hormonal/endocrine disruption",
              "Maternal toxicity",
              "Dose-response relationship",
              "No Observed Adverse Effect Level (NOAEL)",
              "Study species and strain",
              "Exposure timing and duration",
              "Histopathology of reproductive organs",
              "Fetal malformations",
              "Prenatal mortality",
              "Developmental delay",
              "Multigenerational study design",
              "ICH S5(R3) guideline compliance",
              "GLP compliance status",
              "Adverse effects",
              "Adverse events",
              "Safe",
              "Safety",
              "Toxicity"
            ],
            "meshTerms": [
              "Reproductive Toxicity[MeSH]",
              "Developmental Toxicity[MeSH]",
              "Fertility[MeSH]",
              "Teratogenicity[MeSH]",
              "Embryotoxicity[MeSH]",
              "Maternal Toxicity[MeSH]",
              "Dose-Response Relationship, Drug[MeSH]",
              "Safety[MeSH]"
            ],
            "textKeywords": [
              "Developmental Toxicity[tiab]",
              "Embryo-fetal development[tiab]",
              "Prenatal development[tiab]",
              "Postnatal development[tiab]",
              "Teratogenicity[tiab]",
              "Embryotoxicity[tiab]",
              "Growth retardation[tiab]",
              "Neurodevelopmental effects[tiab]",
              "Gametogenesis disruption[tiab]",
              "Hormonal/endocrine disruption[tiab]",
              "Maternal toxicity[tiab]",
              "NOAEL[tiab]",
              "Fetal malformations[tiab]",
              "Prenatal mortality[tiab]",
              "Multigenerational study[tiab]",
              "ICH S5(R3)[tiab]"
            ],
            "types": {
              "fertility": {
                "name": "Fertility and Early Embryonic Development",
                "keywords": [
                  "Fertility Regulation",
                  "Early Embryonic Development",
                  "Fertility and Early Embryonic Development (FEED)",
                  "Fertility assessment",
                  "Gametogenesis",
                  "Implantation",
                  "Early embryonic loss",
                  "Pre-implantation development",
                  "Ovarian/testicular histopathology",
                  "Reproductive organ weights",
                  "Mating performance",
                  "Pregnancy rate",
                  "Sperm parameters (count, motility, morphology)",
                  "Hormonal changes",
                  "Embryotoxicity",
                  "NOAEL (No Observed Adverse Effect Level)",
                  "Maternal toxicity",
                  "Dose-response relationships"
                ],
                "meshTerms": [
                  "Fertility Regulation[MeSH]",
                  "Fertility[MeSH]",
                  "Gametogenesis[MeSH]",
                  "Implantation[MeSH]",
                  "Embryotoxicity[MeSH]",
                  "Maternal Toxicity[MeSH]"
                ],
                "textKeywords": [
                  "Early Embryonic Development[tiab]",
                  "FEED[tiab]",
                  "Fertility assessment[tiab]",
                  "Early embryonic loss[tiab]",
                  "Pre-implantation development[tiab]",
                  "Ovarian/testicular histopathology[tiab]",
                  "Reproductive organ weights[tiab]",
                  "Mating performance[tiab]",
                  "Pregnancy rate[tiab]",
                  "Sperm parameters[tiab]",
                  "Hormonal changes[tiab]",
                  "NOAEL[tiab]"
                ]
              },
              "embryoFetal": {
                "name": "Embryo Foetal Development",
                "keywords": [
                  "Embryo-Fetal Toxicity",
                  "Foetal Development",
                  "Embryo-Fetal Development (EFD)",
                  "Embryo-fetal toxicity",
                  "Teratogenicity",
                  "Fetal malformations",
                  "Growth retardation",
                  "Embryofetal lethality",
                  "Skeletal variations",
                  "Soft tissue malformations",
                  "Maternal toxicity",
                  "Dose levels and exposure",
                  "Timing of exposure",
                  "Histopathological examination",
                  "Species (rodents and rabbits typically)",
                  "NOAEL for developmental effects",
                  "Study design (gestation days exposure)"
                ],
                "meshTerms": [
                  "Foetal Development[MeSH]",
                  "Embryotoxicity[MeSH]",
                  "Teratogenicity[MeSH]",
                  "Fetal Malformations[MeSH]",
                  "Maternal Toxicity[MeSH]"
                ],
                "textKeywords": [
                  "Embryo-Fetal Toxicity[tiab]",
                  "EFD[tiab]",
                  "Embryo-fetal toxicity[tiab]",
                  "Fetal malformations[tiab]",
                  "Growth retardation[tiab]",
                  "Embryofetal lethality[tiab]",
                  "Skeletal variations[tiab]",
                  "Soft tissue malformations[tiab]",
                  "Timing of exposure[tiab]",
                  "NOAEL for developmental effects[tiab]",
                  "gestation days exposure[tiab]"
                ]
              },
              "prenatalPostnatal": {
                "name": "Prenatal and Postnatal Development",
                "keywords": [
                  "Prenatal Exposure Delayed Effects",
                  "Postnatal Development",
                  "Prenatal and Postnatal Development (PPND)",
                  "Pre- and postnatal toxicity",
                  "Toxicity",
                  "Adverse effects",
                  "Adverse events",
                  "Safe",
                  "Safety",
                  "Offspring survival and growth",
                  "Neurobehavioral development",
                  "Organ maturation",
                  "Lactational effects",
                  "Developmental milestones",
                  "Functional impairments",
                  "Multigenerational studies",
                  "Maternal toxicity assessment",
                  "Dose-response relationship"
                ],
                "meshTerms": [
                  "Prenatal Exposure Delayed Effects[MeSH]",
                  "Postnatal Development[MeSH]",
                  "Toxicity[MeSH]",
                  "Safety[MeSH]",
                  "Maternal Toxicity[MeSH]"
                ],
                "textKeywords": [
                  "Postnatal Development[tiab]",
                  "PPND[tiab]",
                  "Pre- and postnatal toxicity[tiab]",
                  "Offspring survival and growth[tiab]",
                  "Neurobehavioral development[tiab]",
                  "Organ maturation[tiab]",
                  "Lactational effects[tiab]",
                  "Developmental milestones[tiab]",
                  "Functional impairments[tiab]",
                  "Multigenerational studies[tiab]",
                  "Maternal toxicity assessment[tiab]"
                ]
              }
            }
          },
          "localTolerance": {
            "name": "Local Tolerance",
            "keywords": [
              "Local Toxicity",
              "Irritation Tests",
              "Sensitization",
              "Dermal Toxicity",
              "Local Tolerance",
              "Injection site reactions",
              "Irritation and inflammation",
              "Tissue necrosis or fibrosis",
              "Histopathology of local tissues",
              "Reversibility of lesions",
              "Route-specific tolerance (IM, SC, IV, topical)",
              "Clinical observations",
              "Toxicity",
              "Adverse effects",
              "Adverse events",
              "Safe",
              "Safety"
            ],
            "meshTerms": [
              "Irritation Tests[MeSH]",
              "Sensitization[MeSH]",
              "Dermal Toxicity[MeSH]",
              "Toxicity[MeSH]",
              "Safety[MeSH]"
            ],
            "textKeywords": [
              "Local Toxicity[tiab]",
              "Local Tolerance[tiab]",
              "Injection site reactions[tiab]",
              "Irritation and inflammation[tiab]",
              "Tissue necrosis or fibrosis[tiab]",
              "Histopathology of local tissues[tiab]",
              "Reversibility of lesions[tiab]",
              "Route-specific tolerance[tiab]",
              "Clinical observations[tiab]"
            ]
          },
          "otherToxicity": {
            "name": "Other Toxicity Studies",
            "keywords": [
              "Immunotoxicity",
              "Nephrotoxicity",
              "Hepatotoxicity",
              "Neurotoxicity",
              "Toxicokinetics",
              "Organ Toxicity",
              "Other Toxicity Studies",
              "Juvenile toxicity",
              "Phototoxicity",
              "Toxicokinetics and toxicodynamics",
              "Carcinogenicity",
              "Toxicity",
              "Adverse effects",
              "Adverse events",
              "Safe",
              "Safety",
              "Genotoxicity",
              "Safety pharmacology",
              "Special toxicity studies (e.g., extractables, leachables)",
              "Species and strain information",
              "GLP compliance"
            ],
            "meshTerms": [
              "Immunotoxicity[MeSH]",
              "Nephrotoxicity[MeSH]",
              "Hepatotoxicity[MeSH]",
              "Neurotoxicity[MeSH]",
              "Toxicokinetics[MeSH]",
              "Phototoxicity[MeSH]",
              "Carcinogenicity[MeSH]",
              "Genotoxicity[MeSH]",
              "Safety[MeSH]"
            ],
            "textKeywords": [
              "Organ Toxicity[tiab]",
              "Other Toxicity Studies[tiab]",
              "Juvenile toxicity[tiab]",
              "Toxicokinetics and toxicodynamics[tiab]",
              "Special toxicity studies[tiab]",
              "extractables[tiab]",
              "leachables[tiab]",
              "Species and strain information[tiab]",
              "GLP compliance[tiab]"
            ]
          }
        }
      }
    }
  },
  "humanStudies": {
    "name": "Human Studies",
    "categories": {
      "pharmacokinetics": {
        "name": "Pharmacokinetics",
        "synonyms": ["PK", "kinetic", "kinetics", "ADME", "Pharmaco-kinetic", "Pharma-cokinetic"],
        "subcategories": {
          "methodOfAnalysis": {
            "name": "Method of Analysis",
            "keywords": [
              "LC-MS/MS",
              "HPLC",
              "LC-MS",
              "LCMS",
              "High-performance liquid chromatography",
              "Liquid Chromatography-Mass Spectrometry",
              "Bioanalytical Method Validation",
              "Chromatography Techniques",
              "Quantitative Assay",
              "Sensitivity and Specificity",
              "Non-compartmental Analysis",
              "Compartmental Modeling",
              "Phoenix WinNonlin"
            ],
            "meshTerms": [
              "Liquid Chromatography-Mass Spectrometry[MeSH]",
              "Chromatography[MeSH]",
              "Sensitivity and Specificity[MeSH]"
            ],
            "textKeywords": [
              "LC-MS/MS[tiab]",
              "HPLC[tiab]",
              "LC-MS[tiab]",
              "LCMS[tiab]",
              "High-performance liquid chromatography[tiab]",
              "Bioanalytical Method Validation[tiab]",
              "Non-compartmental Analysis[tiab]",
              "Compartmental Modeling[tiab]",
              "Phoenix WinNonlin[tiab]"
            ]
          },
          "absorption": {
            "name": "Absorption",
            "keywords": [
              "Bioavailability",
              "First-pass Metabolism",
              "Gastric pH Influence",
              "Gastric Emptying Time",
              "Intestinal Transit Time",
              "Drug Solubility and Permeability",
              "P-glycoprotein",
              "Transporter Proteins",
              "Formulation Effects",
              "CMAX",
              "TMAX",
              "Cmax",
              "Tmax",
              "AUC",
              "Area Under Curve",
              "Peak Concentration",
              "Time to Peak",
              "Maximum Plasma Concentration",
              "Maximum drug concentration"
            ],
            "meshTerms": [
              "Biological Availability[MeSH]",
              "Gastrointestinal Transit[MeSH]",
              "ATP Binding Cassette Transporter, Subfamily B, Member 1[MeSH]",
              "Intestinal Absorption[MeSH]",
              "Drug Absorption[MeSH]"
            ],
            "textKeywords": [
              "First-pass Metabolism[tiab]",
              "Gastric pH[tiab]",
              "P-glycoprotein[tiab]",
              "Formulation Effects[tiab]",
              "Cmax[tiab]",
              "CMAX[tiab]",
              "C max[tiab]",
              "Tmax[tiab]",
              "TMAX[tiab]",
              "T max[tiab]",
              "AUC[tiab]",
              "Area Under Curve[tiab]",
              "Area under the curve[tiab]",
              "peak concentration[tiab]",
              "peak plasma concentration[tiab]",
              "maximum plasma concentration[tiab]",
              "maximum drug concentration[tiab]",
              "time to peak[tiab]",
              "time to maximum concentration[tiab]",
              "bioavailability[tiab]"
            ]
          },
          "distribution": {
            "name": "Distribution",
            "keywords": [
              "Volume of Distribution",
              "Vd",
              "Plasma Protein Binding",
              "Tissue Penetration",
              "Blood-Brain Barrier",
              "Lipophilicity",
              "Tissue Binding",
              "Body Composition Effects",
              "Protein binding",
              "Distribution",
              "Cytochrome"
            ],
            "meshTerms": [
              "Tissue Distribution[MeSH]",
              "Protein Binding[MeSH]",
              "Blood-Brain Barrier[MeSH]"
            ],
            "textKeywords": [
              "Volume of Distribution[tiab]",
              "Vd[tiab]",
              "V d[tiab]",
              "Tissue Penetration[tiab]",
              "Lipophilicity[tiab]",
              "Body Composition[tiab]",
              "Protein binding[tiab]",
              "Plasma protein binding[tiab]",
              "Distribution[tiab]",
              "Cytochrome[tiab]"
            ]
          },
          "metabolism": {
            "name": "Metabolism",
            "keywords": [
              "Hepatic Metabolism",
              "Cytochrome P450 Enzymes",
              "CYP450",
              "CYP",
              "Phase I Metabolism",
              "Phase II Metabolism",
              "Enzyme Induction",
              "Enzyme Inhibition",
              "Metabolite Profiling",
              "Metabolite",
              "Biotransformation",
              "Genetic Polymorphisms"
            ],
            "meshTerms": [
              "Cytochrome P-450 Enzyme System[MeSH]",
              "Metabolic Detoxication, Phase I[MeSH]",
              "Metabolic Detoxication, Phase II[MeSH]",
              "Enzyme Induction[MeSH]",
              "Polymorphism, Genetic[MeSH]"
            ],
            "textKeywords": [
              "Hepatic Metabolism[tiab]",
              "CYP450[tiab]",
              "CYP[tiab]",
              "Metabolite Profiling[tiab]",
              "Metabolite[tiab]",
              "Biotransformation[tiab]",
              "Cytochrome[tiab]"
            ]
          },
          "excretion": {
            "name": "Excretion",
            "keywords": [
              "Renal Clearance",
              "Biliary Excretion",
              "Glomerular Filtration Rate",
              "GFR",
              "Tubular Secretion",
              "Tubular Reabsorption",
              "Half-life",
              "t1/2",
              "Elimination",
              "Clearance",
              "Elimination Rate Constant"
            ],
            "meshTerms": [
              "Metabolic Clearance Rate[MeSH]",
              "Glomerular Filtration Rate[MeSH]",
              "Half-Life[MeSH]",
              "Kidney Tubules[MeSH]"
            ],
            "textKeywords": [
              "Renal Clearance[tiab]",
              "Biliary Excretion[tiab]",
              "Tubular Secretion[tiab]",
              "Elimination Rate[tiab]",
              "Elimination[tiab]",
              "Clearance[tiab]",
              "Half-life[tiab]",
              "t1/2[tiab]",
              "t[tiab]"
            ]
          },
          "specialPopulations": {
            "name": "Pharmacokinetics in Special Populations",
            "keywords": [
              "Pediatric Pharmacokinetics",
              "Geriatric Pharmacokinetics",
              "Pregnancy Pharmacokinetics",
              "Renal Impairment",
              "Hepatic Impairment",
              "Age-related Physiological Changes",
              "Polypharmacy Effects",
              "Dose Adjustment"
            ],
            "meshTerms": [
              "Aged[MeSH]",
              "Child[MeSH]",
              "Pregnancy[MeSH]",
              "Renal Insufficiency[MeSH]",
              "Liver Diseases[MeSH]",
              "Polypharmacy[MeSH]"
            ],
            "textKeywords": [
              "Pediatric Pharmacokinetics[tiab]",
              "Geriatric[tiab]",
              "Dose Adjustment[tiab]",
              "Special Populations[tiab]"
            ]
          },
          "drugInteraction": {
            "name": "Pharmacokinetics Drug Interaction",
            "keywords": [
              "Drug-Drug Interaction",
              "Enzyme Induction",
              "Enzyme Inhibition",
              "Transporter-Mediated Interaction",
              "Pharmacokinetic Interaction Mechanisms",
              "Clinical Significance of Interactions",
              "Therapeutic Drug Monitoring"
            ],
            "meshTerms": [
              "Drug Interactions[MeSH]",
              "Enzyme Induction[MeSH]",
              "Drug Monitoring[MeSH]"
            ],
            "textKeywords": [
              "Drug-Drug Interaction[tiab]",
              "Transporter-Mediated[tiab]",
              "Pharmacokinetic Interaction[tiab]"
            ]
          }
        }
      },
      "pharmacodynamics": {
        "name": "Pharmacodynamics",
        "subcategories": {
          "proposedIndications": {
            "name": "Related to Proposed Indications",
            "keywords": [
              "Dose-Response Relationship",
              "Receptor Binding",
              "Receptor Sensitivity",
              "Agonist",
              "Antagonist",
              "Efficacy",
              "Potency",
              "Therapeutic Index",
              "Mechanism of Action",
              "Target Tissue",
              "Post-Receptor Effects",
              "Signal Transduction",
              "Pharmacologic Effect",
              "Clinical Biomarkers",
              "Therapeutic Window",
              "Receptor Selectivity"
            ],
            "meshTerms": [
              "Dose-Response Relationship, Drug[MeSH]",
              "Receptors, Drug[MeSH]",
              "Drug Agonists[MeSH]",
              "Drug Antagonists[MeSH]",
              "Biomarkers[MeSH]"
            ],
            "textKeywords": [
              "Mechanism of Action[tiab]",
              "Therapeutic Index[tiab]",
              "Signal Transduction[tiab]",
              "Receptor Selectivity[tiab]",
              "Therapeutic Window[tiab]"
            ]
          },
          "drugInteraction": {
            "name": "Pharmacodynamic Drug Interaction",
            "keywords": [
              "Receptor Competition",
              "Synergistic Effect",
              "Antagonistic Effect",
              "Additive Effect",
              "Drug Interaction Mechanism",
              "Receptor Modulation",
              "Enzyme Inhibition",
              "Enzyme Induction",
              "Toxicodynamic Interaction",
              "Therapeutic Drug Monitoring",
              "Drug Resistance",
              "Altered Signal Transduction"
            ],
            "meshTerms": [
              "Drug Interactions[MeSH]",
              "Drug Synergism[MeSH]",
              "Drug Resistance[MeSH]",
              "Signal Transduction[MeSH]"
            ],
            "textKeywords": [
              "Receptor Competition[tiab]",
              "Synergistic Effect[tiab]",
              "Antagonistic Effect[tiab]",
              "Toxicodynamic[tiab]"
            ]
          }
        }
      },
      "efficacy": {
        "name": "Efficacy",
        "subcategories": {
          "placeboControlled": {
            "name": "Placebo-Controlled Studies",
            "keywords": [
              "Randomized Controlled Trial",
              "RCT",
              "Placebo Group",
              "Double-Blind",
              "Blinding",
              "Control Group",
              "Treatment Effect",
              "Statistical Significance",
              "Intention-to-Treat Analysis",
              "Relative Risk Reduction",
              "RRR",
              "Absolute Risk Reduction",
              "ARR",
              "Number Needed to Treat",
              "NNT",
              "Placebos",
              "Placebo Effect",
              "Double-Blind Method",
              "Efficacy",
              "Treatment Outcome",
              "Therapeutic Equivalence",
              "Dose-Response Relationship"
            ],
            "meshTerms": [
              "Randomized Controlled Trial[Publication Type]",
              "Placebos[MeSH]",
              "Double-Blind Method[MeSH]",
              "Treatment Outcome[MeSH]",
              "Therapeutic Equivalency[MeSH]",
              "Dose-Response Relationship, Drug[MeSH]"
            ],
            "textKeywords": [
              "Placebo-Controlled[tiab]",
              "Number Needed to Treat[tiab]",
              "Intention-to-Treat[tiab]",
              "Efficacy[tiab]",
              "Double-Blind[tiab]",
              "Treatment Outcome[tiab]"
            ]
          },
          "activeControlled": {
            "name": "Active-Controlled Studies",
            "keywords": [
              "Active Comparator",
              "Non-Inferiority Trial",
              "Equivalence Trial",
              "Head-to-Head Comparison",
              "Superiority Trial",
              "Dose Comparison",
              "Efficacy Endpoint",
              "Comparative Effectiveness",
              "Treatment Arms",
              "Therapeutic Equivalence",
              "Efficacy",
              "Active control",
              "Clinical Trial"
            ],
            "meshTerms": [
              "Comparative Effectiveness Research[MeSH]",
              "Equivalence Trial[Publication Type]",
              "Therapeutic Equivalency[MeSH]",
              "Clinical Trial[Publication Type]"
            ],
            "textKeywords": [
              "Active Comparator[tiab]",
              "Non-Inferiority[tiab]",
              "Head-to-Head[tiab]",
              "Superiority Trial[tiab]",
              "Efficacy[tiab]",
              "Active control[tiab]",
              "Clinical Trial[tiab]"
            ]
          },
          "uncontrolled": {
            "name": "Uncontrolled Studies",
            "keywords": [
              "Open-Label Study",
              "Single-Arm Study",
              "Observational Study",
              "Case Series",
              "Pilot Study",
              "Exploratory Study",
              "Historical Controls",
              "Therapeutic Use",
              "Treatment Outcome",
              "Non-Randomized Controlled Trials",
              "Pilot Projects",
              "Efficacy"
            ],
            "meshTerms": [
              "Observational Study[Publication Type]",
              "Pilot Projects[MeSH]",
              "Treatment Outcome[MeSH]"
            ],
            "textKeywords": [
              "Open-Label[tiab]",
              "Single-Arm[tiab]",
              "Case Series[tiab]",
              "Historical Controls[tiab]",
              "Open-Label Study[tiab]",
              "Therapeutic Use[tiab]",
              "Non-Randomized Controlled Trials[tiab]",
              "Efficacy[tiab]"
            ]
          },
          "metaAnalysis": {
            "name": "Meta Analysis",
            "keywords": [
              "Meta-Analysis",
              "MetaAnalysis",
              "Systematic Reviews",
              "Treatment Outcome",
              "Randomized Controlled Trials",
              "Review Literature",
              "Evidence-Based Practice",
              "Network Meta-Analysis",
              "Drug Therapy",
              "drug efficacy",
              "treatment effectiveness",
              "comparative efficacy",
              "evidence synthesis",
              "Efficacy"
            ],
            "meshTerms": [
              "Meta-Analysis[Publication Type]",
              "Systematic Review[Publication Type]",
              "Treatment Outcome[MeSH]",
              "Randomized Controlled Trial[Publication Type]",
              "Evidence-Based Practice[MeSH]",
              "Drug Therapy[MeSH]"
            ],
            "textKeywords": [
              "Meta-Analysis[tiab]",
              "MetaAnalysis[tiab]",
              "Systematic Reviews[tiab]",
              "Network Meta-Analysis[tiab]",
              "drug efficacy[tiab]",
              "treatment effectiveness[tiab]",
              "comparative efficacy[tiab]",
              "evidence synthesis[tiab]",
              "Efficacy[tiab]"
            ]
          },
          "paediatrics": {
            "name": "Efficacy in Paediatrics",
            "keywords": [
              "Pediatric Population",
              "Paediatric",
              "Age Stratification",
              "Developmental Pharmacology",
              "Pediatric Dose Adjustment",
              "Growth and Maturation",
              "Pediatric Clinical Trials",
              "Safety and Efficacy in Children",
              "Efficacy",
              "Paediatrics",
              "efficacy in paediatrics",
              "Child",
              "Infant",
              "Adolescent",
              "Treatment Outcome",
              "Dose-Response Relationship Drug",
              "Drug Therapy",
              "Therapeutic Equivalence",
              "Clinical Trials",
              "Randomized Controlled Trials",
              "Safety",
              "Pediatric drug efficacy",
              "Pediatric clinical trial endpoints",
              "Therapeutic outcomes in children",
              "Pediatric dose-response",
              "Pediatric safety and efficacy",
              "Therapeutic effects"
            ],
            "meshTerms": [
              "Child[MeSH]",
              "Pediatrics[MeSH]",
              "Adolescent[MeSH]",
              "Infant[MeSH]",
              "Treatment Outcome[MeSH]",
              "Dose-Response Relationship, Drug[MeSH]",
              "Drug Therapy[MeSH]",
              "Clinical Trial[Publication Type]"
            ],
            "textKeywords": [
              "Pediatric[tiab]",
              "Paediatric[tiab]",
              "Children[tiab]",
              "Developmental Pharmacology[tiab]",
              "Efficacy[tiab]",
              "efficacy in paediatrics[tiab]",
              "Pediatric drug efficacy[tiab]",
              "Therapeutic outcomes in children[tiab]",
              "Pediatric safety and efficacy[tiab]"
            ]
          },
          "dosage": {
            "name": "Dosage",
            "keywords": [
              "Dose-Response Relationship",
              "Therapeutic Dose",
              "Dose Escalation",
              "Maximum Tolerated Dose",
              "MTD",
              "Dose Optimization",
              "Dosing Regimen",
              "Steady-State Concentration",
              "Pharmacodynamics Correlation",
              "Dosage",
              "Dose-Response Relationship, Drug",
              "Dosage Forms",
              "Drug Administration Schedule",
              "Drug Dosage",
              "Therapeutic Equivalence",
              "Drug Therapy",
              "Dose finding",
              "Dose optimization",
              "Dose-ranging study",
              "Dose adjustment",
              "Dose titration",
              "Maximum tolerated dose (MTD)",
              "Minimum effective dose (MED)",
              "Dose-response curve",
              "Fixed dose",
              "Loading dose",
              "Maintenance dose",
              "Dose frequency",
              "Route of administration",
              "Efficacy",
              "Therapeutic effects"
            ],
            "meshTerms": [
              "Dose-Response Relationship, Drug[MeSH]",
              "Maximum Tolerated Dose[MeSH]",
              "Dosage Forms[MeSH]",
              "Drug Administration Schedule[MeSH]",
              "Therapeutic Equivalency[MeSH]",
              "Drug Therapy[MeSH]"
            ],
            "textKeywords": [
              "Dose Escalation[tiab]",
              "Dose Optimization[tiab]",
              "Dosing Regimen[tiab]",
              "Steady-State[tiab]",
              "Dosage[tiab]",
              "Drug Dosage[tiab]",
              "Dose finding[tiab]",
              "Dose-ranging study[tiab]",
              "Dose adjustment[tiab]",
              "Dose titration[tiab]",
              "Maximum tolerated dose[tiab]",
              "Minimum effective dose[tiab]",
              "Fixed dose[tiab]",
              "Loading dose[tiab]",
              "Maintenance dose[tiab]",
              "Efficacy[tiab]",
              "Therapeutic effects[tiab]"
            ]
          }
        }
      },
      "safety": {
        "name": "Safety",
        "subcategories": {
          "adverseReactions": {
            "name": "Adverse Drug Reactions (ADR)",
            "keywords": [
              "Adverse Event",
              "AE",
              "Serious Adverse Event",
              "SAE",
              "Side Effect",
              "Dose-Related Toxicity",
              "Hypersensitivity Reactions",
              "Idiosyncratic Reaction",
              "Causality Assessment",
              "Pharmacovigilance",
              "Risk Management",
              "Safety Signal Detection",
              "Safety",
              "Adverse reactions",
              "Adverse reaction",
              "adverse effect",
              "Adverse effects",
              "Adverse Drug Reaction Reporting Systems",
              "Drug-Related Side Effects Adverse Reactions",
              "Drug Toxicity",
              "Drug Hypersensitivity",
              "Poisoning",
              "Anaphylaxis",
              "Dose-Response Relationship",
              "Serious adverse events",
              "Drug safety monitoring",
              "Toxicity profile",
              "Drug-induced toxicity",
              "Off-target effects",
              "Safety study",
              "Risk management in drug safety"
            ],
            "meshTerms": [
              "Adverse Drug Reaction Reporting Systems[MeSH]",
              "Drug-Related Side Effects and Adverse Reactions[MeSH]",
              "Pharmacovigilance[MeSH]",
              "Drug Toxicity[MeSH]",
              "Drug Hypersensitivity[MeSH]",
              "Poisoning[MeSH]",
              "Anaphylaxis[MeSH]",
              "Dose-Response Relationship, Drug[MeSH]"
            ],
            "textKeywords": [
              "Adverse Event[tiab]",
              "Side Effect[tiab]",
              "Safety Signal[tiab]",
              "Idiosyncratic[tiab]",
              "Safety[tiab]",
              "Adverse reactions[tiab]",
              "Adverse reaction[tiab]",
              "adverse effect[tiab]",
              "Serious adverse events[tiab]",
              "Drug safety monitoring[tiab]",
              "Toxicity profile[tiab]",
              "Drug-induced toxicity[tiab]",
              "Off-target effects[tiab]",
              "Safety signal detection[tiab]"
            ]
          },
          "warningsAndPrecautions": {
            "name": "Special Warnings and Precautions",
            "keywords": [
              "Contraindications",
              "Black Box Warning",
              "Risk Minimization Measures",
              "Monitoring Parameters",
              "Drug Safety Alerts",
              "Precautionary Statements",
              "Warning Labels",
              "Risk-Benefit Analysis",
              "Warnings and Precautions",
              "Risk Management",
              "Safety",
              "Drug Toxicity",
              "Adverse Drug Reaction",
              "Adverse effects",
              "Adverse reaction",
              "Patient Safety",
              "Serious Adverse Events",
              "Special population risk",
              "Use precautions",
              "Precaution",
              "Warning",
              "Safety-related labelling",
              "Drug interaction warnings",
              "Early detection of adverse effects"
            ],
            "meshTerms": [
              "Contraindications[MeSH]",
              "Risk Assessment[MeSH]",
              "Risk Management[MeSH]",
              "Drug Toxicity[MeSH]",
              "Patient Safety[MeSH]"
            ],
            "textKeywords": [
              "Black Box Warning[tiab]",
              "Precautions[tiab]",
              "Risk-Benefit[tiab]",
              "Safety Alert[tiab]",
              "Warnings and Precautions[tiab]",
              "Safety[tiab]",
              "Special population risk[tiab]",
              "Use precautions[tiab]",
              "Drug interaction warnings[tiab]",
              "Early detection of adverse effects[tiab]"
            ]
          },
          "pregnancy": {
            "name": "Pregnancy",
            "keywords": [
              "Teratogenicity",
              "Embryotoxicity",
              "Pregnancy Exposure Registry",
              "Fetal Risk",
              "Pregnancy and Lactation Labeling Rule",
              "PLLR",
              "Gestational Timing of Exposure",
              "Maternal-Fetal Drug Transfer",
              "Reproductive Toxicology",
              "Pregnancy",
              "Pregnant",
              "Lactation",
              "Milk",
              "Breast Feeding",
              "Fetal Development",
              "Safety",
              "Adverse effects",
              "Adverse reaction",
              "Drug Toxicity",
              "Pregnancy safety",
              "Drug use in pregnancy",
              "Lactation safety",
              "Breast milk drug excretion",
              "Maternal-fetal safety",
              "Perinatal outcomes",
              "Pregnancy risk and benefits",
              "Exposure during pregnancy",
              "Neonatal effects",
              "Effects on breastfeeding child",
              "Birth defects risk",
              "Embryo-fetal development risk",
              "Lactation risk assessment",
              "Fetal/neonatal adverse effects",
              "Drug safety in pregnancy",
              "Pregnancy adverse drug reactions",
              "Pregnant women",
              "toxic effects",
              "adverse"
            ],
            "meshTerms": [
              "Pregnancy[MeSH]",
              "Teratogens[MeSH]",
              "Abnormalities, Drug-Induced[MeSH]",
              "Maternal-Fetal Exchange[MeSH]",
              "Lactation[MeSH]",
              "Breast Feeding[MeSH]",
              "Fetal Development[MeSH]",
              "Drug Toxicity[MeSH]"
            ],
            "textKeywords": [
              "Pregnancy[tiab]",
              "Teratogenicity[tiab]",
              "Fetal Risk[tiab]",
              "Gestational[tiab]",
              "Pregnancy safety[tiab]",
              "Drug use in pregnancy[tiab]",
              "Lactation safety[tiab]",
              "Breast milk drug excretion[tiab]",
              "Maternal-fetal safety[tiab]",
              "Perinatal outcomes[tiab]",
              "Exposure during pregnancy[tiab]",
              "Neonatal effects[tiab]",
              "Birth defects risk[tiab]",
              "Pregnancy adverse drug reactions[tiab]"
            ]
          },
          "breastfeeding": {
            "name": "Breast-feeding",
            "keywords": [
              "Drug Transfer into Breast Milk",
              "Milk-to-Plasma Ratio",
              "Infant Exposure",
              "Lactation Risk Assessment",
              "Neonatal Toxicity",
              "Breastfeeding Safety",
              "Drug excretion in breast milk",
              "Breast milk drug transfer",
              "Milk-to-plasma drug concentration ratio",
              "Infant drug exposure via breast milk",
              "Drug safety during breastfeeding",
              "Safety",
              "Breast feeding",
              "Lactation pharmacology",
              "Drug accumulation in breastfed infants",
              "Breast milk:plasma concentration ratio",
              "Transport mechanisms in breast milk",
              "Dose-dependent drug excretion into milk",
              "adverse effects",
              "Adverse reaction",
              "Adverse",
              "toxic effects"
            ],
            "meshTerms": [
              "Breast Feeding[MeSH]",
              "Milk, Human[MeSH]",
              "Lactation[MeSH]",
              "Drug Toxicity[MeSH]"
            ],
            "textKeywords": [
              "Breast Milk[tiab]",
              "Milk-to-Plasma[tiab]",
              "Lactation[tiab]",
              "Breastfeeding[tiab]",
              "Drug excretion in breast milk[tiab]",
              "Breast milk drug transfer[tiab]",
              "Infant drug exposure via breast milk[tiab]",
              "Drug safety during breastfeeding[tiab]",
              "Lactation pharmacology[tiab]",
              "Drug accumulation in breastfed infants[tiab]",
              "Transport mechanisms in breast milk[tiab]"
            ]
          },
          "fertility": {
            "name": "Fertility",
            "keywords": [
              "Reproductive Toxicity",
              "Infertility Risk",
              "Gametotoxicity",
              "Fertility Studies",
              "Fertility safety",
              "Fertility",
              "safety",
              "adverse effects",
              "Adverse reaction",
              "Adverse",
              "toxic effects",
              "Fertility preservation safety",
              "Drug safety in fertility treatment",
              "Infertility treatment adverse effects",
              "Controlled ovarian hyperstimulation toxicity",
              "Ovarian stimulation safety",
              "Fertility drug adverse reactions",
              "Drug Therapy",
              "Infertility"
            ],
            "meshTerms": [
              "Fertility[MeSH]",
              "Reproductive Toxicity[MeSH]",
              "Infertility[MeSH]",
              "Drug Therapy[MeSH]"
            ],
            "textKeywords": [
              "Fertility[tiab]",
              "Gametotoxicity[tiab]",
              "Reproductive Function[tiab]",
              "Fertility safety[tiab]",
              "Fertility preservation safety[tiab]",
              "Drug safety in fertility treatment[tiab]",
              "Infertility treatment adverse effects[tiab]",
              "Controlled ovarian hyperstimulation toxicity[tiab]",
              "Ovarian stimulation safety[tiab]",
              "Fertility drug adverse reactions[tiab]"
            ]
          },
          "overdose": {
            "name": "Overdose",
            "keywords": [
              "Toxic Dose",
              "Poisoning",
              "Acute Toxicity",
              "Overdosage Management",
              "Antidote",
              "Supportive Care",
              "Dose-Limiting Toxicity",
              "Overdose",
              "Safety",
              "adverse effects",
              "Adverse reaction",
              "Adverse",
              "toxic effects",
              "Overdose safety",
              "Toxicity of overdose",
              "Overdose management",
              "Overdose adverse effects",
              "Toxic doses",
              "Overdose prevention",
              "Overdose pharmacovigilance",
              "Overdose risk assessment",
              "Overdose toxicity studies",
              "Overdose treatment protocols",
              "Reversal agents for overdose",
              "Overdose symptoms and management",
              "Overdose safety profile",
              "Overdose in clinical trials",
              "Overdose and reversibility"
            ],
            "meshTerms": [
              "Drug Overdose[MeSH]",
              "Poisoning[MeSH]",
              "Antidotes[MeSH]",
              "Acute Toxicity[MeSH]"
            ],
            "textKeywords": [
              "Overdose[tiab]",
              "Toxic Dose[tiab]",
              "Overdosage[tiab]",
              "Overdose safety[tiab]",
              "Toxicity of overdose[tiab]",
              "Overdose management[tiab]",
              "Overdose adverse effects[tiab]",
              "Overdose prevention[tiab]",
              "Overdose pharmacovigilance[tiab]",
              "Overdose risk assessment[tiab]",
              "Overdose treatment protocols[tiab]",
              "Reversal agents for overdose[tiab]"
            ]
          },
          "postMarketing": {
            "name": "Post-marketing Surveillance",
            "keywords": [
              "Pharmacovigilance",
              "Adverse Event Reporting System",
              "AERS",
              "Risk Evaluation and Mitigation Strategies",
              "REMS",
              "Signal Detection",
              "Real-World Evidence",
              "Safety Monitoring",
              "Post-Authorization Safety Studies",
              "PASS",
              "Post-marketing surveillance",
              "Post-marketing safety monitoring",
              "Pharmacovigilance post-approval",
              "Post-authorization safety studies (PASS)",
              "Periodic Safety Update Reports (PSUR)",
              "Risk management plans post marketing",
              "Adverse drug reaction monitoring post marketing",
              "Postmarketing safety reports",
              "Real-world safety data",
              "Drug safety surveillance",
              "Risk-benefit assessment post marketing",
              "Spontaneous adverse event reporting",
              "Safety follow-up studies",
              "Health authority reporting requirements",
              "Post-authorization efficacy and safety",
              "Post marketing",
              "Safety",
              "adverse effects",
              "Adverse reaction",
              "Adverse",
              "toxic effects"
            ],
            "meshTerms": [
              "Pharmacovigilance[MeSH]",
              "Product Surveillance, Postmarketing[MeSH]",
              "Adverse Drug Reaction Reporting Systems[MeSH]",
              "Risk Assessment[MeSH]"
            ],
            "textKeywords": [
              "Post-marketing[tiab]",
              "REMS[tiab]",
              "Real-World Evidence[tiab]",
              "Signal Detection[tiab]",
              "Post-marketing surveillance[tiab]",
              "Post-marketing safety monitoring[tiab]",
              "Pharmacovigilance post-approval[tiab]",
              "Periodic Safety Update Reports[tiab]",
              "Risk management plans post marketing[tiab]",
              "Postmarketing safety reports[tiab]",
              "Real-world safety data[tiab]",
              "Drug safety surveillance[tiab]",
              "Safety follow-up studies[tiab]"
            ]
          }
        }
      }
    }
  }
}
